Skip to content

STUDY TO OBSERVE EFFECTS OF VARIOUS NEWLY AVAILABLE MANAGEMENT MODALITIES LIKE PHAKIC IOL(A TYPE OF INTRA-OCULAR LENS IMPLANTED IN EYE) , OCCLUTAB(A TYPE OF CONTRAST BASED APP IN A DIGITAL TABLET) WITH THE CONVENTIONAL EYE - PATCHING FOR PATIENTS OF A TYPE OF VISUAL IMPAIRMENT KNOWN AS AMBLYOPIA

STUDY TO EVALUATE EFFICACY OF DIFFERENT TREATMENT MODALITIES FOR PATIENTS OF AMBLYOPIA

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030394
Enrollment
80
Registered
2021-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H530- Amblyopia ex anopsia

Interventions

Intervention1: OCCLUTAB: Occlusion of better eye and to play a contrast based game after wearing a particular glasses on the - Occlutab device. Intervention2: PHAKIC INTRAOCULAR LENS: To implant Phaki

Sponsors

Dr Arvind Kumar Morya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: To evaluate the efficacy of three treatment modalities - Occlutab , Phakic IOL and conventional ocular - patching in the patients of high myopic anisometropia and isometropia between the age of 10-23 years of both sexes.

Exclusion criteria

Exclusion criteria: 1. Amblyopic patients of less than 10 and more than 23 years of age. 2. Amblyopic patients with hypermetropia. 3. Any history of ocular trauma, glaucoma. 4. Patients having Endothelial chamber depth of less than 2.8 mm. 5. Unstable refractive error.

Design outcomes

Primary

MeasureTime frame
To note improvement in the Distant visual acuity in logMAR.Timepoint: 3 months.

Secondary

MeasureTime frame
To measure improvement in contrast sensitivity and stereo acuity.Timepoint: 3 months.

Countries

India

Contacts

Public ContactDr Arvind Kumar Morya

All India Institute Of Medical Sciences, Jodhpur

bulbul.morya@gmail.com8003996598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026